Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

TXG 10x Genomics Inc

11,65

0,00 (0,00%)

Pré-mercado

Última atualização: 10:55:32

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

02/24/2025

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

10x Genomics (NASDAQ:TXG)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025

Click aqui para mais gráficos 10x Genomics.

10x Genomics (NASDAQ:TXG)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025

Click aqui para mais gráficos 10x Genomics.

Notícias 10x Genomics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 26 de Fevereiro de 2025 (16 horas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 26 de Fevereiro de 2025 (16 horas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 24 de Fevereiro de 2025 (3 dias atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 24 de Fevereiro de 2025 (3 dias atrás) • Edgar (US Regulatory)

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis
Domingo, 23 de Fevereiro de 2025 (4 dias atrás) • PR Newswire (US)

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference
Terça, 18 de Fevereiro de 2025 (1 semana atrás) • PR Newswire (US)

Form S-8 - Securities to be offered to employees in employee benefit plans
Quinta, 13 de Fevereiro de 2025 (2 semanas atrás) • Edgar (US Regulatory)

Form 8-K - Current report
Quarta, 12 de Fevereiro de 2025 (2 semanas atrás) • Edgar (US Regulatory)

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025
Quarta, 12 de Fevereiro de 2025 (2 semanas atrás) • PR Newswire (US)

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology
Quinta, 6 de Fevereiro de 2025 (3 semanas atrás) • PR Newswire (US)

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025
Terça, 28 de Janeiro de 2025 (4 semanas atrás) • PR Newswire (US)

Form 8-K - Current report
Segunda, 13 de Janeiro de 2025 (1 mês atrás) • Edgar (US Regulatory)

Mais Notícias de 10x Genomics Inc

Invesco Financials S&P U...

Vontobel Financial Produ...

Vontobel Financial Produ...

Exchange Traded

Fundo Invest Imobiliario...

BNP Paribas Issuance

Achari Ventures Holdings... (PK)

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições